ARTICLE | Company News
Electrofect AS, Boehringer Ingelheim GmbH International deal
February 28, 2000 8:00 AM UTC
Boehringer received a non-exclusive license to use Electrofect's electroporation technology to promote uptake of DNA into cells in the field of oncology. ...